Member Info for Pacman121

@Guy

My point is they haven't dumped it but instead are increasing exposure. Why waste time on a bad egg if you could be making profit elsewhere. It's a double loss.

If we get sales we'll be off. If we get a supply contract like NCYT did (and ours can be much smaller than the one awarded to them) then you can say goodbye to your mortgage. Will be shocked if we don't hear something this month given how fast things are moving in country.

He is very well connected with BC and Danaher to be fair, and probably the only reason we have the Beckman partnership. That will draw revenue otherwise BC would have dropped it by now 100%. They cant afford to have unpopular things on offer, dilutes the assurance on other products and ties up their resources.

Remember how positive this board got on the way up from 40p? There are soooo many reasons to be here. Prob is people jump in for the bag bag bag before luch and then start feeling sick if they get locked in = spiral of dispair. Bet a bunch sold out at 50p after waiting for ages and thought opps. Also much easier to feed doubt in ones mind compared to positivity, especially when its money on the line.

The ICMR lab validation came back with 100% sensitivity and 100% specificity don't forget.

The question everyone should be asking is why did the ICMR not only approve GDR's test, but also clinically approve it the same week it stated they were accepting CE IVD marked tests, if they were not intending to use it and use it soon? Can we turn that into a negative?

@RiskIsReward

India have a huge shortfall in tests hence the emergency use of other CE/FDA etc. approved tests.
Situation is dire
PCR tests are more accurate so more likely to get the situation under control, prob worth the extra bucks for that benefit.
Lots of very wealthy people in India who can afford an accurate test
Still about a 200% mark up for GDR'd PCR test in India.

All products developed and tested and now at or close to commercial stage save for the POC. I'd favour a buy out over a placing given sub £50m MC. Snoop still gutted over getting 3 or 4 trades in a row wrong plus entering NCYT just before it crashed now bashing GDR under DrDre Twitter handle based on 'noise in the city:. Erm is that the same noise that wiped out his cash. Thought he was ok at one point but he's now very bitter. Never get why people bash stock they are not in while trying to be genuine from multiple accounts. Careful.

Trades here are people trading for a penny point or 2. That's trading. All going against themselves at the moment. Little spirt to 80p in seconds on Friday shows what can happen.

Clarification on the UNICEF contracts would be good.

The only thing causing the drop is PI's selling. This company doesnt leak so buys are based on potential and sells on fear. Remember when PI's took it all the way down to 40p in Jan only to chase it back to 165 in less than 2 weeks.

Sales will come. Won't take much to cover the entire existing market cap. So much pending. If GDR didn't alienate its own shareholders and cut and paste nothing statements to their emails this would be much higher. Just need a little sentiment boost like several times before.

If it's just internal then thats one thing but if its external as well then the plot thickens.

@Jay

Have they said they are manufacturing beads for demand? I only ask because as you'll be aware they had a sizeable stockpile, so if they are manufacturing then that implies sales doesn't it?

RNS containing:

Unicef HCV contracts
Sales on the PHE framework
Beckman sales
India sales/supply contract
NHS intent on AIHL test
DoD contract

Would be nice.

GDR have employees in India as well as the established relationship with Divoc who seem to love the test. India need to move fast now so pace likely to pick up. Good for them and good for us. Testing will go through the roof as travel picks up and inevitably cases increase again post lockdown.

Rubbish being spouted again by some. Test can run on the Biomeki7. BC don't target india specifically but can distribute there. They focus in US and Europe, hence the compatible use of GDR's tests on other manufacturers equipment. India is Thermofisher as per website. Also the tests can be utilised manually where needs be. Automation is obviously a lot faster but there is the option for both.

Think it's quite clear the test will run on the Thermofisher machines in India. The good thing about the Genedrive bead is that it is compatible with almost everything.

Peel could have walked this up just as easily as they walked it down today. Plenty of money watching this from the sidelines waiting for the break.

No idea. All you get out of GDR is we will update the market when appropriate'.

I'd love to work for a PR company like Walbrook. Cut Paste, Cut Paste, Cut Paste..... easy £

Yep. LTA suggested 2 order of min £500k each, and thats just one channel.

India orders likely building up as we speak. Can't believe how quick GDR got a clinical approval over there last week. That was a big win for me. Also we know AIHL test is launching in summer and the NHS already want it. If the US take it up as well then let the midcap discussions begin. Plus everything else, poc, fda etc.

Would the Indian regulatory body have formally approved and then taken the trouble to clinically validate GDR's if they had no intention of using it? Highly unlikely. Scored 100% in both fields. Is there even another test that can do that? People wanting news everyday don't realise how much has aready been given. Hate to say it but it is very much sheep mentality here now. Great for traders as it's like clockwork.

Market doesn't know anything as GDR don't leak, jeez they barely out the positives. Major RNS coming. Giving the rate things are moving in India I'd say very, very soon. As others have stated we though this market was lost, now it's achieved in 3 days what the FDA hasn't in 11 months.

GDR will need to sign off on contracts and arrange to get product into country (think for use with Thermofisher equipment in India if the go for automation over manual use). That's probably being done this week.

*in